Pfizer/Pharmacia update
This article was originally published in The Tan Sheet
Executive Summary
Pharmacia CEO Fred Hassan will earn annual base salary of $1.5 mil. with an annual incentives target of 125% of base salary as Pfizer vice chairman, according to Pfizer's Aug. 14 1S-4 filing with SEC. Hassan also will be entitled to receive an equity award in the first year of 900,000 Pfizer stock options. Upon retirement, he will serve as a Pfizer consultant earning $850,000 per year. In other personnel news, Pharmacia senior execs offered positions at Pfizer include Pharmacia's President-R&D Goran Ando, MD, and Chief Scientific Officer Phillip Needleman, PhD. Notable absentees from the list include Pharmacia's Senior VP-Global Regulatory Affairs John Landis and President-North American Operations Mark Spiers...